Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

OBJECTIVE. To characterize hydroxychloroquine exposure in patients with rheumatic disease receiving long-term hydroxychloroquine compared to target concentrations with reported antiviral activity against the 2019 coronavirus SARS-CoV-2. METHOD. We evaluated total hydroxychloroquine concentrations in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Rheumatol
Egile Nagusiak: Balevic, Stephen J., Hornik, Christoph P., Green, Thomas P., Clowse, Megan E.B., Gonzalez, Daniel, Maharaj, Anil R., Schanberg, Laura E., Eudy, Amanda M., Swamy, Geeta K., Hughes, Brenna L., Cohen-Wolkowiez, Michael
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655510/
https://ncbi.nlm.nih.gov/pubmed/32393664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.200493
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak